Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03320798|
Recruitment Status : Completed
First Posted : October 25, 2017
Last Update Posted : October 25, 2017
|Condition or disease||Intervention/treatment|
|Bullous Pemphigoid||Other: Data record|
|Study Type :||Observational|
|Actual Enrollment :||178 participants|
|Official Title:||Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients|
|Actual Study Start Date :||October 1, 2013|
|Actual Primary Completion Date :||October 1, 2014|
|Actual Study Completion Date :||March 1, 2015|
group "Bullous pemphigoid"
Patients consulting at dermatology department of Reims Teaching Hospital for bullous pemphigoid between 1997 and 2011.
Other: Data record
- neurological disease [ Time Frame: Day 0 ]neurological disease are dementia (Alzheimers disease or other dementia), Parkinson's syndrome and stroke. Diagnosis of dementia was carried out in several ways: after examination by a neurologist or geriatrician, when the Mini Mental State was less than or equal to 17 or in the presence of a demonstrated and clinically evident dementia.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03320798